THE CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME - AN EXPERIMENT OF NATURE IN GLYCOSYLATION

B. Winchester , P. Clayton , N. Mian , E. di-Tomaso
Biochemical Society Transactions 23 ( 1) 185 -188

19
1995
Challenges in the clinical development of PI3K inhibitors

Cristian Massacesi , Emmanuelle Tomaso , Nathalie Fretault , Samit Hirawat
Annals of the New York Academy of Sciences 1280 ( 1) 19 -23

35
2013
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.

Dan G. Duda , Christopher G. Willett , Marek Ancukiewicz , Emmanuelle Tomaso
Oncologist 15 ( 6) 577 -583

80
2010
Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer

Christopher G Willett , Dan G Duda , Emmanuelle dI Tomaso , Yves Boucher
Nature Clinical Practice Oncology 4 ( 5) 316 -321

59
2007
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor

Emmanuelle DI TOMASO , Christine Fritsch , Marie-Caroline GERMA , Cristian MASSACESI

2022
Synergistic combinations of pi3k-and mek-inhibitors

Christine Fritsch , Xizhong Huang , Markus Boehm , Emmanuelle DI TOMASO

2013
Angiogenesic profile in sporadic and NF2-related schwannomas

Emmanuelle di Tomaso , Anat Stemmer-Rachamimov , Rakesh Jain , Scott Plotkin
Cancer Research 68 4434 -4434

1
2008
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

Emmanuelle di Tomaso , Herman D. Suit , Napoleone Ferrara , M. Ancukiewicz
Cancer Research 60 ( 19) 5565 -5570

607
2000
Efficacy, safety, and changes in angiogenic markers following sunitinib monotherapy in patients with advanced hepatocellular carcinoma: Experience from a phase II study.

Emmanuelle di Tomaso , Dushyant Sahani , Lawrence Blaszkowsky , Vivek Sindhwani
Molecular Cancer Therapeutics 6

2
2007
Wrapping and Tapping Anastomosis between Engrafted Endothelial Networks and Host Vasculature

Emmanuelle di Tomaso , Dai Fukumura , Lance L Munn , Delphine Lacorre
The FASEB Journal 24

2010
Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

Tracy T. Batchelor , Dan G. Duda , Emmanuelle di Tomaso , Marek Ancukiewicz
Journal of Clinical Oncology 28 ( 17) 2817 -2823

426
2010
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma

Dan G. Duda , Emmanuelle di Tomaso , Yves Boucher , Marek Ancukiewicz
Clinical Ovarian Cancer 4 ( 1) 26 -33

23
2011
380
2005
Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis.

Rakesh K. Jain , Lance L. Munn , Gang Cheng , Shan Liao
Blood 118 ( 17) 4740 -4749

126
2011
Angiogenesis in brain tumours

Rakesh K. Jain , Emmanuelle di Tomaso , Dan G. Duda , Jay S. Loeffler
Nature Reviews Neuroscience 8 ( 8) 610 -622

1,015
2007
Overcoming Phosphatidylinositol 3-Kinase (PI3K) Activation in Breast Cancer: Emerging PI3K Inhibitors

Cristian Massacesi , Emmanuelle di Tomaso , Patrick Urban , Caroline Germa
The Journal of OncoPathology 3 ( 1) 27 -39

6
2015